Patents by Inventor Nadia M. J. Rupniak

Nadia M. J. Rupniak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL[-BENZAMIDE
    Publication number: 20210401822
    Abstract: The present invention relates to discloses a pharmaceutical composition of 2,4,6-trifluoro-N-[6-(1-methyl-piperidin-4-ylcarbonyl)-pyridin-2-yl]-benzamide and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: September 14, 2021
    Publication date: December 30, 2021
    Inventors: Alison Pilgrim, James F. White, Nadia M.J. Rupniak
  • Compounds that inhibit cholinesterase
    Patent number: 8101782
    Abstract: Compounds that inhibit cholinesterase activity and, upon hydrolysis release a pharmacologically active agent. The compounds of the invention are employed in methods to treat an individual. The pharmacologically active agent obtained by hydrolysis of the compound can treat, for example, a nervous system condition, a cholinergic deficiency and conditions or diseases associated with a deficiency in a pharmacologically active agent, such as acetylcholine.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: January 24, 2012
    Assignee: Colucid Pharmaceuticals, Inc.
    Inventors: Nadia M. J. Rupniak, James F. White, Kazumi Shiosaki, J. David Leander, Shoucheng Du, Daniel J. Coughlin
  • COMPOSITION OF 2,4,6- TRIFLUORO-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE
    Publication number: 20100256187
    Abstract: The present invention relates to discloses a pharmaceutical composition of 2,4,6-trifluoro-N-[6-(1-methyl-piperidin-4-ylcarbonyl)-pyridin-2-yl]-benzamide and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: April 2, 2010
    Publication date: October 7, 2010
    Applicant: CoLucid Pharmaceuticals, Inc.
    Inventors: Alison Pilgrim, James F. White, Nadia M.J. Rupniak
  • Methods for promoting wakefulness
    Publication number: 20090048229
    Abstract: The present invention relates to methods of promoting wakefulness in an individual by administering a carbamoyl ester or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 18, 2008
    Publication date: February 19, 2009
    Inventors: Nadia M.J. Rupniak, James F. White
  • Compounds that inhibit cholinesterase
    Publication number: 20080261950
    Abstract: Compounds that inhibit cholinesterase activity and, upon hydrolysis release a pharmacologically active agent. The compounds of the invention are employed in methods to treat an individual. The pharmacologically active agent obtained by hydrolysis of the compound can treat, for example, a nervous system condition, a cholinergic deficiency and conditions or diseases associated with a deficiency in a pharmacologically active agent, such as acetylcholine.
    Type: Application
    Filed: February 4, 2008
    Publication date: October 23, 2008
    Applicant: CoLucid Pharmaceuticals, Inc.
    Inventors: Nadia M. J. Rupniak, James F. White, Kazumi Shiosaki, J. David Leander, Shoucheng Du, Daniel J. Coughlin